27Apr
[Video] Six Things You Need to Know About Life Sciences M&A During and After COVID-19
While life sciences M&A activity soared to a new high in 2019, the uncertainty surrounding the pandemic has led to a slow down in deal making activity. However, as the crisis in the U.S. subsides and the U.S. economy stabilizes, we expect life...
By:
Arnall Golden Gregory LLP
Related
In RGC Gaslamp v. Ehmcke Sheet Metal Co., the Fourth Appellate District held that a trial court prop...
Read More >
Employers found to have misclassified employees as independent contractors will no longer face the p...
Read More >
The start of a new year always brings a fresh batch of employment concerns. While some workplace iss...
Read More >
What Happened: • On May 7, 2019, Governor Jay Inslee of Washington State signed House Bill 1607 in...
Read More >
- DOJ’s update offers additional insights into its approach to evaluating corporate compliance prog...
Read More >
Did you know that when a private sector employer has evidence that a union has lost support from a m...
Read More >